Medications

Novel agent promising for the treatment of schizophrenia

(HealthDay)—For patients with an acute exacerbation of schizophrenia, SEP-363856, a non-D2-receptor-binding drug that has agonist activity at trace amine-associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A receptors, ...

Diseases, Conditions, Syndromes

Allergy season concerns during the pandemic

It's spring and that means allergy season is on the way. But this year it will be arriving in the midst of a global pandemic and with this comes a host of new concerns to contemplate. The Queen's Gazette spoke with Dr. Anne ...

Diseases, Conditions, Syndromes

Fecal transplants beat C. diff superbug 90% of the time

First reported in ancient China, human fecal transplants have made a comeback in modern medicine. Evidence shows this treatment can be effective in treating C. difficile—a gastrointestinal infection that can cause symptoms ...

Diseases, Conditions, Syndromes

COVID-19: The tale of one virus and two testing methods

When a new virus emerges that infects and sickens humans, the wheels of innovation start turning quickly in the world of health care and biomedical research. Teams versed in different aspects of laboratory medicine work together ...

Cardiology

What's the best blood thinner if you have a-fib?

(HealthDay)—People with the heart condition atrial fibrillation often use blood thinners to help prevent a stroke. Now a new study suggests one of those medications might stand out as safer and more effective.

Radiology & Imaging

Study looks at EVALI findings in teens

The first study to examine both chest X-ray and CT imaging findings in teenagers with electronic (e-)cigarette or vaping product use-associated lung injury (EVALI) was published today in the journal Radiology.

page 34 from 40